The association of weight loss from anti‐obesity medications or bariatric surgery and apnea‐hypopnea index in obstructive sleep apnea
Obesity Reviews · 2024
DOI: 10.1111/obr.13697 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Obesity Reviews, 2024. Verfasst von Brian W Locke und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary and Critical Care, Department of Internal Medicine, University of Utah, Salt Lake City, Utah, USA. Hauptthemen laut MEDLINE: Sleep Apnea, Obstructive, Bariatric Surgery, Anti-Obesity Agents. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
Introduction
Weight loss is recommended for individuals with obstructive sleep apnea (OSA) and overweight or obesity, but there is limited evidence to guide the selection of weight management strategies for patients who do not lose sufficient weight with diet and lifestyle changes. We evaluated the relationship between weight loss caused by pharmacologic or surgical interventions and subsequent improvement in OSA by the apnea‐hypopnea index (AHI).
Methods
PubMed, Cochrane CENTRAL, and EMBASE were searched for randomized trials comparing pharmacologic or surgical obesity interventions to usual care, placebo, or no treatment in adults with OSA. The association between percentage weight loss and AHI change between randomization and last follow‐up was evaluated using meta‐regression. PROSPERO: CRD42022378853.
Results
Ten eligible trials ( n = 854 patients) were included. Four ( n = 211) assessed bariatric surgery, and 6 ( n = 643) assessed pharmacologic interventions over a median follow‐up of 13 months (interquartile range 6–26 months). The linear best estimate of the change in AHI is 0.45 events per hour (95% Confidence Interval 0.18 to 0.73 events per hour) for every 1% body weight lost.
Conclusions
Weight loss caused by medication or surgery caused a proportionate improvement of the AHI. Providers could consider extrapolating from this relationship when advising patients of the expected effects of other pharmacologic or surgical interventions without direct evidence in OSA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pulmonary and Critical Care, Department of Internal Medicine, University of Utah, Salt Lake City, Utah, USA.
- Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, Utah, USA.
- Department of Pharmacy Practice, School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia.
- Department of Social and Administrative Pharmacy, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand.
- IDEAS Center, Veterans Affairs Salt Lake City Healthcare System, Salt Lake City, Utah, USA.
ORCID-Profile: Brian W Locke, Ainhoa Gomez-Lumbreras, Chanthawat Patikorn, Nathorn Chaiyakunapruk
Förderung
- NHLBI NIH HHS
- NCATS NIH HHS
Zitieren
APA
Locke, B. W., Gomez-Lumbreras, A., Tan, C. J., Nonthasawadsri, T., Veettil, S. K., Patikorn, C., & Chaiyakunapruk, N. (2024). The association of weight loss from anti‐obesity medications or bariatric surgery and apnea‐hypopnea index in obstructive sleep apnea. Obesity Reviews. https://doi.org/10.1111/obr.13697
Vancouver
Locke BW, Gomez-Lumbreras A, Tan CJ, Nonthasawadsri T, Veettil SK, Patikorn C, et al. The association of weight loss from anti‐obesity medications or bariatric surgery and apnea‐hypopnea index in obstructive sleep apnea. Obesity Reviews. 2024. doi:10.1111/obr.13697
BibTeX
@article{Locke2024,
author = {Locke, Brian W and Gomez-Lumbreras, Ainhoa and Tan, Chia Jie and Nonthasawadsri, Teerawat and Veettil, Sajesh K and Patikorn, Chanthawat and Chaiyakunapruk, Nathorn},
title = {The association of weight loss from anti‐obesity medications or bariatric surgery and apnea‐hypopnea index in obstructive sleep apnea},
journal = {Obesity Reviews},
year = {2024},
doi = {10.1111/obr.13697}
}
EUVIMED